Research Article

Safety Assessment of Zigbir®: A Polyherbal Formulation in Sprague-Dawley Rats

Table 4

Clinical chemistry data (mean ± SD) of male rats after oral administration of Zigbir® for 90 days.

Parameters Control250 mg/kg500 mg/kg1000 mg/kgControl recovery1000 mg/kg recovery

Total protein (g%)7.55 ± 0.477.63 ± 0.487.66 ± 0.567.58 ± 0.517.47 ± 0.477.40 ± 0.28
Albumin (g%)3.42 ± 0.453.29 ± 0.433.49 ± 0.393.57 ± 0.423.65 ± 0.223.58 ± 0.26
Bilirubin (mg%)0.65 ± 0.070.68 ± 0.110.72 ± 0.080.69 ± 0.080.72 ± 0.080.66 ± 0.05
Blood sugar (mg%)88.50 ± 10.2892.10 ± 10.6490.90 ± 9.1688.90 ± 8.2796.40 ± 7.0997.40 ± 12.28
Triglycerides (mg%)105.30 ± 8.56102.10 ± 7.23107.50 ± 7.43108.20 ± 3.33105.00 ± 4.64107.20 ± 1.30
Cholesterol (mg%)61.30 ± 5.6858.60 ± 2.7263.30 ± 6.5064.20 ± 4.9863.80 ± 4.0262.20 ± 6.30
BUN (mg%)37.20 ± 5.0538.10 ± 7.1441.10 ± 4.6139.60 ± 6.3640.20 ± 2.2839.20 ± 4.44
Creatinine (mg%)0.99 ± 0.140.98 ± 0.110.99 ± 0.110.98 ± 0.101.02 ± 0.101.04 ± 0.14
AST (IU/L)62.00 ± 4.0061.10 ± 4.5860.90 ± 3.3164.20 ± 4.7661.80 ± 8.1160.40 ± 6.19
ALT (IU/L)43.80 ± 6.5638.90 ± 7.8840.40 ± 8.9641.50 ± 6.0838.80 ± 3.1937.60 ± 6.31
ALP (IU/L)68.80 ± 6.8369.90 ± 5.9970.80 ± 6.58115.40** ± 12.4073.00 ± 8.4966.00 ± 5.10
γGT (U/L)14.10 ± 2.7316.70 ± 4.5014.80 ± 2.9014.90 ± 3.2818.80 ± 4.2117.00 ± 1.58
LDH (IU/L)358.30 ± 31.75354.00 ± 26.99345.30 ± 28.80361.60 ± 28.48357.40 ± 32.26337.00 ± 33.59
CPK (IU/L)63.40 ± 4.9962.20 ± 4.9667.20 ± 4.1364.60 ± 3.5763.40 ± 3.7867.40 ± 2.97
Sodium (mmol/L)141.30 ± 5.62142.20 ± 6.58141.20 ± 6.71136.50 ± 5.66138.60 ± 1.14140.40 ± 6.15
Chloride (mmol/L)101.60 ± 3.47101.50 ± 2.92101.80 ± 3.16101.40 ± 2.88102.20 ± 2.68101.80 ± 2.77
Potassium (mmol/L)3.70 ± 0.353.58 ± 0.153.66 ± 0.223.75 ± 0.233.81 ± 0.103.84 ± 0.06
Calcium (mg%)9.64 ± 0.669.55 ± 0.519.63 ± 0.539.78 ± 0.749.96 ± 0.5310.04 ± 0.72
Phosphorus (mg%)4.30 ± 0.324.31 ± 0.424.06 ± 0.284.08 ± 0.434.12 ± 0.574.34 ± 0.05

P < 0.01 versus control group.